Fig. 2From: Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitisPruritus scores in the treatment and control groups of the study. PVAS (a) and pruritus timed episodes (b) scores were evaluated at baseline and after 4 and 8 weeks of treatment. Data reported as mean ± SEM (n = 6 vs 6)Back to article page